Evaluation of asthma control using patient based measures and peak expiratory flow rate

West Indian Medical Journal

Volumn 58, Issue 3, 2009, Pages 214-218

  Pinto Pereira, L M ^a   Boodoo, S ^a   Dindial, K A ^a   Hosein, A ^a   Seemungal, T A R ^a   Bekele, I ^a  

^a UNIVERSITY OF THE WEST INDIES   (Trinidad and Tobago)

Author keywords

[No Author keywords available]

Indexed keywords

BECLOMETASONE; BUDESONIDE PLUS FORMOTEROL; SALBUTAMOL; THEOPHYLLINE;

ADOLESCENT; ADULT; AGED; ARTICLE; ASTHMA; CENTRAL AMERICA; CONTROLLED STUDY; DISEASE CONTROL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT ASSESSMENT; PATIENT EDUCATION; PEAK EXPIRATORY FLOW; SEX DIFFERENCE;

ADOLESCENT; ADULT; ALBUTEROL; ANTI-ASTHMATIC AGENTS; ASTHMA; BECLOMETHASONE; BRONCHODILATOR AGENTS; CONFIDENCE INTERVALS; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PATIENT SATISFACTION; PEAK EXPIRATORY FLOW RATE; QUESTIONNAIRES; RESPIRATORY FUNCTION TESTS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 71949106525     PISSN: 00433144     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Masoli M, Fabian D, Holt S, Beasley R. The global burden of asthma: executive summary of the GINA Dissemination Committee Report Allergy 2004; 59: 469-478
2. Global Initiative for Asthma (GINA). Global strategy for asthma management and prevention. GINA 2002; http://www.ginasthma.com/
3. Boulet LP, Phillips R, O'Byrne P, Becker A. Evaluation of asthma control by physicians and patients: comparison with current guidelines. Can Respir J 2002; 9: 417-423 (Pubitemid 36204210)
4. Rabe KF, Adachi M, Lai CK, Soriano JB, Vermeire PA, Weiss KB et al. Worldwide severity and control of asthma in children and adults: the global asthma insights and reality surveys. J Allergy Clin Immunol; 114: 40-47
5. Bateman ED. Using clinical measures of disease control to reduce the burden of asthma. Pharmacoeconomics 2001; 19 (Suppl 2): 7-12.
6. Haahtela T, Laitinen LA. Asthma programme in Finland 1994-2004. Report of a Working Group. Clin Exp Allergy 1996; 26 (Suppl 1: i-ii): 1-24.
7. Sealy P, Bird B, Thomas C, St Aimee N, Pinto Pereira LM. Control of asthma in patients attending the Chest Clinic in Trinidad. West Indian Med J 2002; 51S: 33
8. Villaroel-Stuart AR, Gibson TT, Griffith TN, Rangoo-Madhosingh C, Samaroo D, Matthew J et al. A preliminary report of patients' perception of disease severity, treatment and control of asthma in three health institutions in Trinidad. Carib Med J 2006; 66: 20.
9. Nathan RA, Sorkness CA, Kosinski M, Schatz M, Li JT, Marcus P et al. Development of the Asthma Control Test: A survey for assessing asthma control. J Allergy Clin Immunol 2004; 113: 59-65. (Pubitemid 38096162)
10. Lenoir M, Williamson A, Stanford RH, Stempel DA. Assessment of asthma control in a general population of asthmatics. Curr Med Res Opin 2006; 22: 17-22. (Pubitemid 43106903)
11. Royal College of Physicians' three questions. RCPLondon. pp. 638-734 http://www.rcplondon.ac.uk/news/news.asp?PR-id=70
12. Lang DM, Sherman MS, Polansky M. Guidelines and realities of asthma management. The Philadelphia story. Arch Inter Med 1997; 157: 1193-1200
13. Williams MV, Baker DW, Honig EG, Lee TM, Nowlan A. Inadequate literacy is a barrier to asthma knowledge and self-care. Chest 1998; 114: 1008-1015 (Pubitemid 28495894)
14. Godard P, Huas D, Sohier B, Pribil C, Boucot I. Asthma control in general practice: a cross-sectional survey of 16 580 patients. Presse Med 2005; 34: 1351-1357 (Pubitemid 41617517)
15. McCoy L, Redelings M, Sorvillo F, Simon PA. A multiple cause-of-death analysis of asthma mortality in the United States, 1990-2001. J Asthma 2005; 42: 757-763
16. Moorman JE, Mannino DM. Increasing U.S. asthma mortality rates: who is really dying? J Asthma 2001; 38: 65-71.
17. Rabe KF, Vermeire PA, Soriano JB, Maier WC. Clinical management of asthma in 1999: the Asthma Insights and Reality in Europe (AIRE) study. Eur Respir J 2000; 16: 802-807
18. Haughney J, Barnes G, Partridge M, Cleland J. The Living & Breathing Study: a study of patients' views of asthma and its treatment. Prim Care Respir J 2004; 13: 28-35. (Pubitemid 38248440)
19. Lai CK, De Guia TS, Kim YY, Kuo SH, Mukhopadhyay A, Soriano JB et al. Asthma control in Asia-Pacific region: The Asthma Insights and reality in Asia-Pacific Study. J Allergy Clin Immunol 2003; 111: 263-268 (Pubitemid 36228544)
20. Schatz M, Sorkness CA, Li JT, Marcus P, Murray JJ, Nathan RA et al. Asthma Control Test: reliability, validity and responsiveness in patients not previously followed by asthma specialists. J Allergy Clin Immunol 2006; 117: 549-556 (Pubitemid 43340217)
21. Bateman EF, Frith LF, Braunstein GL. Achieving guideline-based asthma control: does the patient benefit? Eur Respir J 2002; 20: 588-595
22. Bateman ED, Boushey HA, Bousquet J, Busse WW, Clark TJ, Pauwels RA et al. GOAL Investigators Group. Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma Control study. Am J Respir Crit Care Med 2004; 170: 836-844 (Pubitemid 39346477)
23. Chen H, Gould MK, Blanc PD, Miller DP, Kamath TV, Lee JH et al. For the TENOR Study Group. Asthma control, severity, and quality of life: quantifying the effect of uncontrolled disease. J Allergy Clin Immunol 2007; 120: 396-402
24. Kruithof N, Cleland J, Moffat M, Crescenzi K, Price D. Patient set treatment goals: a tool to measure patients' perceptions of changes in asthma outcomes. Primary Care Respir J 2004; 13: 118-119
25. Boulet LP, Boulet V, Milot J. How should we quantify asthma control? Aproposal. Chest 2002; 122: 2217-2223 (Pubitemid 36051162)